A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
Clinical trial NCT01254071 · COMPLETED
Trial details
- NCT number
- NCT01254071
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-10
- Primary completion
- 2010-12-21
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.